106 related articles for article (PubMed ID: 5002750)
1. In vitro effect of various hypoglycemic agents on the hepatic and pancreatic protein synthesis in the rat.
Wacker A; Chandra P; Wacker D
Horm Metab Res; 1971 Sep; 3(5):357-8. PubMed ID: 5002750
[No Abstract] [Full Text] [Related]
2. [The effect of oral antidiabetics on the biosynthesis of proinsulin in the rat].
Tjioe TO; Wacker A
Arzneimittelforschung; 1972 Nov; 22(11):1890-2. PubMed ID: 4633587
[No Abstract] [Full Text] [Related]
3. [Experimental studies on the mechanism of thrombocyte aggregation inhibition caused by sulfonylurea compounds. 2. Modification of blood sugar and thrombocyte aggregation by oral antidiabetics].
Losert W; Hoder A; Scholz C
Arzneimittelforschung; 1975 Feb; 25(2):170-9. PubMed ID: 804311
[No Abstract] [Full Text] [Related]
4. Changes in plasma amino acids levels and "in vivo" gluconeogenesis from alanine in rats chronically treated with sulfonylureas.
Alemany M; Palou A; Codina J; Herrera E
Diabete Metab; 1978 Sep; 4(3):181-6. PubMed ID: 101403
[No Abstract] [Full Text] [Related]
5. [Extrapancreatic effects of sulfonylurea compounds. IV. Increase of the effect of insulin due to tolbutamide, glibornuride, and glibenclamide in vitro].
Beyer J; Gather W; Schöffling K
Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2179. PubMed ID: 4198966
[No Abstract] [Full Text] [Related]
6. Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide).
Loubatiéres A; Mariani MM; Ribes G; Alric R
Acta Diabetol Lat; 1973; 10(2):261-82. PubMed ID: 4200675
[No Abstract] [Full Text] [Related]
7. The potentiating effect of the simultaneous administration of tolbutamide, glibenclamide, and gliclazide on the development of alloxan-induced diabetes in rats.
Katsumata K; Katsumata Y
Horm Metab Res; 1990 Jan; 22(1):51-2. PubMed ID: 2106472
[No Abstract] [Full Text] [Related]
8. [Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide)].
Loubatières A; Ribes G; Mariani MM; Alric R
Acta Diabetol Lat; 1973; 10(2):261-82. PubMed ID: 4200420
[No Abstract] [Full Text] [Related]
9. [Extrapancreatic effects of sulfonylurea compounds. 3. Studies on the additional blood sugar decreasing and antilipolytic effect of tolbutamide, glibornuride, and glibenclamide on completely pancreatectomized dogs, chronically treated with insulin during acute experiment and following pretreatment with sulfonylurea compounds using small doses of sulfonylurea].
Beyer J; Cordes U; Sell G; Schöffling K
Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2176. PubMed ID: 4198965
[No Abstract] [Full Text] [Related]
10. Insulinotrophic drugs. Effect on intestinal abosorption of sugar.
Botros M; Selim R; Ghoneim K; Ghareeb A; Wahba N
Diabetes; 1974 Feb; 23(2):112-6. PubMed ID: 4204422
[No Abstract] [Full Text] [Related]
11. [Effects of some sulfonylurea derivatives on liver extracts cultivated in vitro. I. Morphology].
Conti G; Hadhazy C; Cappelli B; Spreca A; Gotzos V
Pharm Acta Helv; 1971 Aug; 46(8):497-507. PubMed ID: 5092968
[No Abstract] [Full Text] [Related]
12. Uptake of glibornuride by microdissected pancreatic islets.
Täljedal IB
Horm Res; 1974; 5(4):211-6. PubMed ID: 4210148
[No Abstract] [Full Text] [Related]
13. [Extrapancreatic effects of sulfonylurea compounds. I. Studies on the effect of tolbutamide and glibornuride on blood sugar, nonesterified fatty acids, glycerin, lactate and pyruvate in the pancreatectomized dog chronically treated with insulin].
Beyer J; Cordes U; Krall H; Sell G; Schöffling K
Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2167. PubMed ID: 4679246
[No Abstract] [Full Text] [Related]
14. Effect of hypoglycemic sulfonylureas on hepatic fructose metabolism in the rat.
Schönborn J; Poser W; Panten U; Hasselblatt A
Horm Metab Res; 1974 Jul; 6(4):284-3. PubMed ID: 4213055
[No Abstract] [Full Text] [Related]
15. Investigation of the effects of sulfonylurea exposure on pancreatic beta cell metabolism.
Brennan L; Hewage C; Malthouse JP; McClenaghan NH; Flatt PR; Newsholme P
FEBS J; 2006 Nov; 273(22):5160-8. PubMed ID: 17054712
[TBL] [Abstract][Full Text] [Related]
16. Mode of action of oral hypoglycaemic agents. II. Sulphonylureas & biguanides in rats.
Augusti KT; Kurup PA
Indian J Biochem; 1969 Mar; 6(1):36-9. PubMed ID: 4332123
[No Abstract] [Full Text] [Related]
17. Hyaluronidase-induced inhibition of the insulinotropic action of sulfonylureas, leucine, and glucagon in rodent isolated pancreatic islets.
Macchi IA; Zeytinoğlu FN
Horm Metab Res; 1976 Mar; 8(2):92-6. PubMed ID: 177348
[TBL] [Abstract][Full Text] [Related]
18. [Long term in vivo and in vitro effect of sulfonylurea compounds on the islands of Langerhans of rat pancreas. Existence of a feedback mechanism between storage and synthesis apparatus of beta cells].
Schatz H; Laube H; Steinle D; Federlin K; Pfeiffer EF
Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1378-84. PubMed ID: 417494
[No Abstract] [Full Text] [Related]
19. [Glibornuride, a new high-effective antidiabetic agent. Pharmacological and biochemical comparative studies in various animal species and animal experimental models].
Lorch E; Gey KF; Sommer P
Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2154. PubMed ID: 4198964
[No Abstract] [Full Text] [Related]
20. [Pharmacologic study with glisoxepide and other blood sugar reducing sulfonamide derivatives in metabolically healthy subjects and diabetics].
Haupt E; Beyer J; Schöffling K
Arzneimittelforschung; 1974 Mar; 24(0):418-25. PubMed ID: 4211557
[No Abstract] [Full Text] [Related]
[Next] [New Search]
